{"id":27383,"date":"2026-10-14T09:00:29","date_gmt":"2026-10-14T02:00:29","guid":{"rendered":"https:\/\/www.nanovest.io/blog\/?p=27383"},"modified":"2026-10-14T09:00:29","modified_gmt":"2026-10-14T02:00:29","slug":"jnj-tertekan-unh-catat-pemulihan","status":"publish","type":"post","link":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/","title":{"rendered":"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Laporan keuangan kuartal III 2026 dari dua perusahaan besar sektor kesehatan Amerika Serikat menunjukkan respons pasar yang berbeda terhadap peningkatan prospek laba.<\/span><\/p>\n<p><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=JNJ&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DJNJ\"><span style=\"font-weight: 400;\">Johnson &amp; Johnson (JNJ)<\/span><\/a><span style=\"font-weight: 400;\"> dan <\/span><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=UNH&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DUNH\"><span style=\"font-weight: 400;\">UnitedHealth Group (UNH)<\/span><\/a><span style=\"font-weight: 400;\"> sama-sama menaikkan proyeksi kinerja tahunan.<\/span><span style=\"font-weight: 400;\"> Namun, kedua saham justru mengakhiri perdagangan Selasa, 13 Oktober 2026, di zona merah.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Saham JNJ anjlok 5,73% setelah investor menyoroti pertumbuhan bisnis teknologi medis yang lebih rendah dari harapan. Sementara itu, UNH sempat menguat hingga 5% berkat peningkatan proyeksi laba, sebelum memangkas seluruh kenaikannya dan ditutup turun tipis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pergerakan tersebut memperlihatkan bagaimana investor tidak hanya memperhatikan kenaikan proyeksi laba, tetapi juga perkembangan operasional yang mendukung keberlanjutan pertumbuhan masing-masing perusahaan.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_88 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Daftar Isi <\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#Johnson_Johnson_Turun_573_Meski_Naikkan_Proyeksi_Laba\" >Johnson &amp; Johnson Turun 5,73% Meski Naikkan Proyeksi Laba\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#Bisnis_Farmasi_JNJ_Tetap_Tumbuh_Tremfya_Naik_68\" >Bisnis Farmasi JNJ Tetap Tumbuh, Tremfya Naik 68%\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#UnitedHealth_Naikkan_Proyeksi_Laba_untuk_Ketiga_Kalinya\" >UnitedHealth Naikkan Proyeksi Laba untuk Ketiga Kalinya\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#Earnings_Sektor_Kesehatan_AS_Apa_yang_Perlu_Dicermati_Investor\" >Earnings Sektor Kesehatan AS: Apa yang Perlu Dicermati Investor?\u00a0<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Johnson_Johnson_Turun_573_Meski_Naikkan_Proyeksi_Laba\"><\/span><b>Johnson &amp; Johnson Turun 5,73% Meski Naikkan Proyeksi Laba\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Saham Johnson &amp; Johnson ditutup pada US$248,61 pada 13 Oktober 2026, turun US$15,12 atau 5,73% dari sesi sebelumnya. Penurunan tersebut terjadi meskipun perusahaan kembali menaikkan proyeksi pendapatan dan laba untuk tahun penuh 2026.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perhatian investor terutama tertuju pada unit teknologi medis JNJ, yang mencatat pertumbuhan penjualan sebesar 2,5%. Kinerja ini menjadi perhatian di tengah pertumbuhan bisnis farmasi perusahaan yang relatif lebih kuat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Menurut CFO Johnson &amp; Johnson Joe Wolk, terdapat dua faktor utama yang memengaruhi bisnis perangkat medis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pertama, sebuah studi di Inggris pada awal 2026 mempertanyakan manfaat penggunaan pompa jantung perusahaan dalam sejumlah prosedur berisiko tinggi. Perkembangan tersebut menjadi tantangan bagi bisnis perangkat medis yang berkaitan dengan teknologi jantung.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kedua, konflik geopolitik di Timur Tengah turut memengaruhi penjualan. Sejumlah negara di kawasan tersebut mengalihkan sebagian anggaran untuk kebutuhan pertahanan, sehingga memengaruhi belanja layanan kesehatan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Manajemen menilai kebutuhan terhadap teknologi medis masih ada dan memperkirakan tekanan tersebut dapat mereda memasuki 2027.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Di luar kinerja kuartalan, JNJ juga tengah mengevaluasi masa depan bisnis ortopedinya. Sebelumnya, terdapat laporan mengenai pembicaraan dengan Apollo Global Management terkait potensi penjualan unit tersebut. <\/span><span style=\"font-weight: 400;\">Namun, Wolk menyampaikan bahwa manajemen kini lebih memilih opsi pemisahan bisnis atau <\/span><i><span style=\"font-weight: 400;\">spin-off<\/span><\/i><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pertimbangan tersebut berkaitan dengan penurunan valuasi perusahaan teknologi medis yang dapat memengaruhi harga jual apabila unit ortopedi dilepas kepada pihak lain.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dengan posisi kas yang kuat, JNJ menilai pemisahan bisnis berpotensi memberikan fleksibilitas lebih besar dan memungkinkan unit ortopedi berkembang sebagai perusahaan tersendiri.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bisnis_Farmasi_JNJ_Tetap_Tumbuh_Tremfya_Naik_68\"><\/span><b>Bisnis Farmasi JNJ Tetap Tumbuh, Tremfya Naik 68%\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Di tengah perlambatan unit teknologi medis, bisnis farmasi tetap menjadi salah satu pendorong pertumbuhan Johnson &amp; Johnson. Penjualan segmen farmasi perusahaan meningkat 7,7% menjadi sekitar US$16,8 miliar, didukung pertumbuhan sejumlah obat untuk kanker, penyakit autoimun, dan gangguan kesehatan mental.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Salah satu produk dengan pertumbuhan menonjol adalah Tremfya, obat biologis suntik untuk psoriasis dan penyakit radang usus. Penjualan Tremfya meningkat 68%, seiring perluasan penggunaannya dalam pengobatan berbagai kondisi inflamasi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Manajemen JNJ memperkirakan Tremfya berpotensi berkembang menjadi produk dengan penjualan tahunan lebih dari US$10 miliar dalam jangka panjang. Namun, angka tersebut masih merupakan ekspektasi perusahaan, bukan pendapatan yang telah terealisasi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Selain Tremfya, JNJ juga mengembangkan pasar untuk Icotyde, obat psoriasis berbentuk pil yang dikonsumsi sekali sehari. Sejak diperkenalkan pada awal 2026, Icotyde telah memperoleh sekitar 20.000 resep, dengan basis tenaga kesehatan yang meresepkannya mencapai sekitar 9.000 orang.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Manajemen menjelaskan bahwa sebagian pasien masih menerima sampel gratis, sehingga jumlah resep tersebut belum sepenuhnya tercermin dalam pendapatan produk.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Menariknya, penggunaan Icotyde tidak hanya berasal dari dokter spesialis kulit, tetapi juga dokter layanan primer dan tenaga kesehatan lainnya. JNJ menilai kehadiran obat oral dapat memperluas akses pengobatan psoriasis, terutama bagi pasien yang belum menggunakan terapi biologis berbentuk suntikan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perusahaan juga menyatakan bahwa peningkatan penggunaan Icotyde sejauh ini tidak mengurangi permintaan Tremfya.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Meski bisnis farmasi menunjukkan pertumbuhan, respons pasar terhadap laporan JNJ memperlihatkan bahwa investor masih memperhitungkan tantangan di unit teknologi medis serta perkembangan restrukturisasi portofolio perusahaan.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"UnitedHealth_Naikkan_Proyeksi_Laba_untuk_Ketiga_Kalinya\"><\/span><b>UnitedHealth Naikkan Proyeksi Laba untuk Ketiga Kalinya\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Sementara Johnson &amp; Johnson menghadapi tekanan dari bisnis perangkat medis, UnitedHealth Group melaporkan perkembangan positif dalam upaya pemulihan profitabilitas.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">UnitedHealth membukukan pendapatan kuartal III 2026 yang melampaui estimasi Wall Street dan kembali menaikkan proyeksi laba tahunan. Perusahaan kini memperkirakan laba per saham disesuaikan minimal US$20,50 untuk tahun penuh 2026, meningkat dari proyeksi sebelumnya sebesar US$19,50-US$20,00.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Revisi tersebut menjadi kenaikan proyeksi laba ketiga yang diumumkan UnitedHealth sepanjang tahun ini. Salah satu faktor pendukungnya adalah biaya medis yang lebih rendah dari perkiraan, sehingga membantu meningkatkan profitabilitas perusahaan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perkembangan tersebut menjadi bagian dari program pemulihan UnitedHealth yang diluncurkan pada 2025, setelah perusahaan menghadapi tekanan dari kenaikan biaya layanan kesehatan, penurunan keuntungan, dan tantangan regulasi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kinerja terbaru menunjukkan adanya kemajuan dalam pelaksanaan program tersebut, meskipun perusahaan masih perlu mempertahankan pengendalian biaya dan memperbaiki hasil operasional secara berkelanjutan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Respons awal investor terhadap laporan UNH cukup positif. Saham perusahaan sempat melonjak hingga 5% dalam perdagangan Selasa. Namun, kenaikan tersebut berangsur berkurang hingga saham UNH akhirnya ditutup di US$377,76, turun 0,20% dari sesi sebelumnya.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sejak awal 2026, saham UnitedHealth telah meningkat sekitar 14%, setelah sebelumnya mengalami tekanan besar pada Januari akibat usulan kenaikan pembayaran Medicare Advantage 2027 yang lebih rendah dari ekspektasi pasar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Di sisi lain, Berkshire Hathaway sebelumnya juga mengungkapkan bahwa perusahaan telah menjual seluruh kepemilikannya di UnitedHealth, yang berjumlah lebih dari lima juta saham.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dengan demikian, meskipun proyeksi laba UNH terus membaik, pergerakan sahamnya menunjukkan bahwa investor masih mempertimbangkan keberlanjutan pemulihan bisnis dan risiko yang dihadapi sektor asuransi kesehatan.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Earnings_Sektor_Kesehatan_AS_Apa_yang_Perlu_Dicermati_Investor\"><\/span><b>Earnings Sektor Kesehatan AS: Apa yang Perlu Dicermati Investor?\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Laporan JNJ dan UNH menunjukkan dua kondisi bisnis yang berbeda dalam sektor kesehatan Amerika Serikat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bagi Johnson &amp; Johnson, pertumbuhan farmasi tetap menjadi kekuatan utama. Namun, investor masih perlu memperhatikan kinerja perangkat medis, perkembangan penjualan produk baru, dan keputusan perusahaan terkait pemisahan bisnis ortopedi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sementara itu, bagi UnitedHealth, fokus utamanya adalah kemampuan mempertahankan pengendalian biaya medis dan merealisasikan proyeksi laba yang telah dinaikkan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perbedaan model bisnis juga menjadi pertimbangan penting. JNJ memperoleh pendapatan dari pengembangan dan penjualan obat serta perangkat medis, sedangkan UNH memiliki eksposur besar terhadap bisnis asuransi kesehatan dan pengelolaan layanan kesehatan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Karena itu, faktor yang memengaruhi profitabilitas keduanya tidak selalu sama. Penurunan saham JNJ sebesar 5,73% dan pelemahan tipis UNH sebesar 0,20% pada 13 Oktober memperlihatkan bahwa peningkatan proyeksi keuangan tidak otomatis menghasilkan respons positif di pasar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Untuk menilai prospek kedua saham, investor perlu mencermati realisasi pendapatan, margin keuntungan, perkembangan biaya operasional, serta konsistensi pertumbuhan bisnis pada kuartal berikutnya.<\/span><\/p>\n<div style=\"background: linear-gradient(135deg, #111827, #1F2937); padding: 24px; border-radius: 14px; margin: 28px 0; text-align: center; color: #ffffff;\">\n<p style=\"margin: 0 0 8px; font-size: 21px; line-height: 1.4; color: #ffffff;\"><strong>Outlook Naik, Saham Turun? Pantau JNJ &amp; UNH!<\/strong><\/p>\n<p style=\"max-width: 650px; margin: 0 auto 20px; font-size: 14px; line-height: 1.7; color: #e5e7eb;\">JNJ dan UNH sama-sama menaikkan proyeksi laba, tetapi pasar merespons dengan cara berbeda. Pantau saham sektor kesehatan AS dan peluang investasi lainnya melalui Nanovest, serta ikuti perkembangan earnings dan update pasar terbaru di News &amp; Artikel Tips Nanovest.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: center; gap: 10px;\">\n<p><a style=\"display: inline-flex; align-items: center; justify-content: center; padding: 11px 18px; border-radius: 8px; background: #7C3AED; color: #ffffff; font-size: 14px; font-weight: bold; text-decoration: none;\" href=\"https:\/\/www.nanovest.io\/\" target=\"_blank\" rel=\"noopener noreferrer\">Investasi di Nanovest<br \/>\n<\/a><\/p>\n<p><a style=\"display: inline-flex; align-items: center; justify-content: center; padding: 11px 18px; border-radius: 8px; background: #ffffff; color: #7c3aed; font-size: 14px; font-weight: bold; text-decoration: none;\" href=\"https:\/\/www.nanovest.io\/blog\/\" target=\"_blank\" rel=\"noopener noreferrer\">Baca News &amp; Artikel Tips \u2192<br \/>\n<\/a><\/p>\n<\/div>\n<p style=\"max-width: 650px; margin: 16px auto 0; font-size: 11px; line-height: 1.55; color: #9ca3af;\">Investasi memiliki risiko. Lakukan riset mandiri dan pertimbangkan profil risiko sebelum mengambil keputusan investasi.<span style=\"color: #333333; font-size: 14px;\">\u00a0<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Laporan keuangan kuartal III 2026 dari dua perusahaan besar sektor kesehatan Amerika Serikat menunjukkan respons pasar yang berbeda terhadap peningkatan prospek laba. Johnson &amp; Johnson (JNJ) dan UnitedHealth Group (UNH) sama-sama menaikkan proyeksi kinerja tahunan. Namun, kedua saham justru mengakhiri perdagangan Selasa, 13 Oktober 2026, di zona merah. Saham JNJ anjlok 5,73% setelah investor menyoroti<\/p>\n","protected":false},"author":35,"featured_media":27384,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[80,39],"tags":[74,552,28,52,553,29],"class_list":["post-27383","post","type-post","status-publish","format-standard","has-post-thumbnail","category-berita","category-saham-as","tag-berita","tag-johnson-johnson-jnj","tag-saham-amerika","tag-saham-as","tag-unitedhealth-unh","tag-us-stocks"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Maretha Putri\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita\" \/>\n\t\t<meta property=\"og:description\" content=\"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-14T02:00:29+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-14T02:00:29+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nanovest\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:title\" content=\"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"position\":2,\"name\":\"Berita\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#listItem\",\"name\":\"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#listItem\",\"position\":3,\"name\":\"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#newsarticle\",\"name\":\"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita\",\"headline\":\"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan\",\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Contrasting-Healthcare-Market-Landscape.webp\",\"width\":1536,\"height\":1024,\"caption\":\"Ilustrasi kontras kinerja Johnson & Johnson yang tertekan oleh perlambatan bisnis perangkat medis dan UnitedHealth Group yang menunjukkan pemulihan, dengan simbol peralatan medis serta grafik pergerakan saham kedua perusahaan.\"},\"datePublished\":\"2026-10-14T09:00:29+07:00\",\"dateModified\":\"2026-10-14T09:00:29+07:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#webpage\"},\"articleSection\":\"Berita, Saham AS, Berita, Johnson &amp; Johnson (JNJ), Saham Amerika, Saham AS, UnitedHealth (UNH), US Stocks\",\"dateline\":\"Published on Oktober 14, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\",\"name\":\"Nanovest\",\"description\":\"Nanovest is an Indonesian digital investment and asset trading platform operated by PT Tumbuh Bersama Nano.\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"email\":\"care@nanovest.io\",\"foundingDate\":\"2022-08-24\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":0,\"maxValue\":150},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#organizationLogo\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nanovest\",\"https:\\\/\\\/twitter.com\\\/nanovest_io\",\"https:\\\/\\\/www.instagram.com\\\/nanovest.io\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5Y5fD2FApTWMc0c2mlxzIg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nano-vest\\\/\",\"https:\\\/\\\/www.threads.com\\\/@nanovest.io\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/\",\"name\":\"Maretha Putri\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png\",\"width\":96,\"height\":96,\"caption\":\"Maretha Putri\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#webpage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/\",\"name\":\"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita\",\"description\":\"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Contrasting-Healthcare-Market-Landscape.webp\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#mainImage\",\"width\":1536,\"height\":1024,\"caption\":\"Ilustrasi kontras kinerja Johnson & Johnson yang tertekan oleh perlambatan bisnis perangkat medis dan UnitedHealth Group yang menunjukkan pemulihan, dengan simbol peralatan medis serta grafik pergerakan saham kedua perusahaan.\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/jnj-tertekan-unh-catat-pemulihan-27383\\\/#mainImage\"},\"datePublished\":\"2026-10-14T09:00:29+07:00\",\"dateModified\":\"2026-10-14T09:00:29+07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"name\":\"Nanovest\",\"alternateName\":\"Blog Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita<\/title>\n\n","aioseo_head_json":{"title":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","description":"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.","canonical_url":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/#listItem","position":1,"name":"Home","item":"https:\/\/www.nanovest.io/blog\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","position":2,"name":"Berita","item":"https:\/\/www.nanovest.io/blog\/category\/berita\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#listItem","name":"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#listItem","position":3,"name":"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan","previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}}]},{"@type":"NewsArticle","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#newsarticle","name":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","headline":"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan","author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp","width":1536,"height":1024,"caption":"Ilustrasi kontras kinerja Johnson & Johnson yang tertekan oleh perlambatan bisnis perangkat medis dan UnitedHealth Group yang menunjukkan pemulihan, dengan simbol peralatan medis serta grafik pergerakan saham kedua perusahaan."},"datePublished":"2026-10-14T09:00:29+07:00","dateModified":"2026-10-14T09:00:29+07:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#webpage"},"isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#webpage"},"articleSection":"Berita, Saham AS, Berita, Johnson &amp; Johnson (JNJ), Saham Amerika, Saham AS, UnitedHealth (UNH), US Stocks","dateline":"Published on Oktober 14, 2026."},{"@type":"Organization","@id":"https:\/\/www.nanovest.io/blog\/#organization","name":"Nanovest","description":"Nanovest is an Indonesian digital investment and asset trading platform operated by PT Tumbuh Bersama Nano.","url":"https:\/\/www.nanovest.io/blog\/","email":"care@nanovest.io","foundingDate":"2022-08-24","numberOfEmployees":{"@type":"QuantitativeValue","minValue":0,"maxValue":150},"logo":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#organizationLogo","width":250,"height":250,"caption":"site-logo-color"},"image":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/nanovest","https:\/\/twitter.com\/nanovest_io","https:\/\/www.instagram.com\/nanovest.io\/","https:\/\/www.youtube.com\/channel\/UC5Y5fD2FApTWMc0c2mlxzIg","https:\/\/www.linkedin.com\/company\/nano-vest\/","https:\/\/www.threads.com\/@nanovest.io"]},{"@type":"Person","@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author","url":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/","name":"Maretha Putri","image":{"@type":"ImageObject","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#authorImage","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png","width":96,"height":96,"caption":"Maretha Putri"}},{"@type":"WebPage","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#webpage","url":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/","name":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","description":"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/#website"},"breadcrumb":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#breadcrumblist"},"author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"creator":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp","@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#mainImage","width":1536,"height":1024,"caption":"Ilustrasi kontras kinerja Johnson & Johnson yang tertekan oleh perlambatan bisnis perangkat medis dan UnitedHealth Group yang menunjukkan pemulihan, dengan simbol peralatan medis serta grafik pergerakan saham kedua perusahaan."},"primaryImageOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/#mainImage"},"datePublished":"2026-10-14T09:00:29+07:00","dateModified":"2026-10-14T09:00:29+07:00"},{"@type":"WebSite","@id":"https:\/\/www.nanovest.io/blog\/#website","url":"https:\/\/www.nanovest.io/blog\/","name":"Nanovest","alternateName":"Blog Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","inLanguage":"id-ID","publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas","og:type":"article","og:title":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","og:description":"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.","og:url":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/","og:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp","og:image:secure_url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp","og:image:width":1536,"og:image:height":1024,"article:published_time":"2026-10-14T02:00:29+00:00","article:modified_time":"2026-10-14T02:00:29+00:00","article:publisher":"https:\/\/www.facebook.com\/nanovest","twitter:card":"summary_large_image","twitter:site":"@nanovest_io","twitter:title":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","twitter:description":"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.","twitter:creator":"@nanovest_io","twitter:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Contrasting-Healthcare-Market-Landscape.webp"},"aioseo_meta_data":{"post_id":"27383","title":"JNJ Tertekan Bisnis Medis, UNH Catat Pemulihan - Berita","description":"Saham JNJ anjlok 5,73% meski proyeksi laba naik, sementara UNH kembali menaikkan outlook 2026. Simak earnings dan prospek dua raksasa kesehatan AS.","keywords":null,"keyphrases":{"focus":{"keyphrase":"jnj","score":0,"analysis":[]},"additional":[{"keyphrase":"unh","score":0},{"keyphrase":"johnson & johnson","score":0},{"keyphrase":"unitedhealth","score":0}]},"primary_term":{"category":80},"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-10-14 01:55:56","updated":"2026-10-14 02:00:29","focus_keyword":"jnj","additional_keywords":[{"word":"unh","score":78,"items":{"introductionKeyword":{"score":3},"keyphraseLength":{"score":9},"keyphraseDensity":{"score":9},"functionWordsInKeyphrase":{"score":9},"textCompetingLinks":{"score":9},"imageKeyphrase":{"score":3}}},{"word":"johnson & johnson","score":78,"items":{"introductionKeyword":{"score":3},"keyphraseLength":{"score":9},"keyphraseDensity":{"score":9},"functionWordsInKeyphrase":{"score":9},"textCompetingLinks":{"score":9},"imageKeyphrase":{"score":3}}},{"word":"unitedhealth","score":78,"items":{"introductionKeyword":{"score":3},"keyphraseLength":{"score":9},"keyphraseDensity":{"score":9},"functionWordsInKeyphrase":{"score":9},"textCompetingLinks":{"score":9},"imageKeyphrase":{"score":3}}}],"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/category\/berita\/\" title=\"Berita\">Berita<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tJohnson &amp; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.nanovest.io/blog\/"},{"label":"Berita","link":"https:\/\/www.nanovest.io/blog\/category\/berita\/"},{"label":"Johnson &#038; Johnson Tertekan Bisnis Medis, UnitedHealth Catat Pemulihan","link":"https:\/\/www.nanovest.io/blog\/berita\/jnj-tertekan-unh-catat-pemulihan-27383\/"}],"_links":{"self":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/27383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/comments?post=27383"}],"version-history":[{"count":2,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/27383\/revisions"}],"predecessor-version":[{"id":27386,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/27383\/revisions\/27386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media\/27384"}],"wp:attachment":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media?parent=27383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/categories?post=27383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/tags?post=27383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}